Barclays’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $329K | Buy |
72,842
+26,084
| +56% | +$118K | ﹤0.01% | 3264 |
|
2025
Q1 | $207K | Sell |
46,758
-29,104
| -38% | -$129K | ﹤0.01% | 3302 |
|
2024
Q4 | $594K | Buy |
75,862
+6,640
| +10% | +$52K | ﹤0.01% | 2952 |
|
2024
Q3 | $910K | Buy |
69,222
+56,244
| +433% | +$739K | ﹤0.01% | 2674 |
|
2024
Q2 | $156K | Sell |
12,978
-12,760
| -50% | -$153K | ﹤0.01% | 3171 |
|
2024
Q1 | $418K | Sell |
25,738
-24,699
| -49% | -$401K | ﹤0.01% | 2937 |
|
2023
Q4 | $344K | Buy |
50,437
+44,135
| +700% | +$301K | ﹤0.01% | 3226 |
|
2023
Q3 | $34K | Sell |
6,302
-1,015
| -14% | -$5.48K | ﹤0.01% | 3748 |
|
2023
Q2 | $49K | Sell |
7,317
-40,092
| -85% | -$268K | ﹤0.01% | 3684 |
|
2023
Q1 | $237K | Buy |
47,409
+37,550
| +381% | +$188K | ﹤0.01% | 3052 |
|
2022
Q4 | $48K | Sell |
9,859
-54,586
| -85% | -$266K | ﹤0.01% | 3791 |
|
2022
Q3 | $929K | Buy |
64,445
+61,634
| +2,193% | +$888K | ﹤0.01% | 2193 |
|
2022
Q2 | $43K | Sell |
2,811
-2,984
| -51% | -$45.6K | ﹤0.01% | 3784 |
|
2022
Q1 | $68K | Sell |
5,795
-54,183
| -90% | -$636K | ﹤0.01% | 3853 |
|
2021
Q4 | $972K | Buy |
59,978
+42,509
| +243% | +$689K | ﹤0.01% | 2224 |
|
2021
Q3 | $498K | Buy |
17,469
+10,615
| +155% | +$303K | ﹤0.01% | 2611 |
|
2021
Q2 | $232K | Sell |
6,854
-27,147
| -80% | -$919K | ﹤0.01% | 2827 |
|
2021
Q1 | $1.03M | Buy |
34,001
+21,857
| +180% | +$661K | ﹤0.01% | 2284 |
|
2020
Q4 | $602K | Sell |
12,144
-36,411
| -75% | -$1.8M | ﹤0.01% | 2244 |
|
2020
Q3 | $1.87M | Sell |
48,555
-3,449
| -7% | -$132K | ﹤0.01% | 1547 |
|
2020
Q2 | $2.25M | Buy |
52,004
+41,223
| +382% | +$1.78M | ﹤0.01% | 1400 |
|
2020
Q1 | $281K | Sell |
10,781
-17,281
| -62% | -$450K | ﹤0.01% | 2395 |
|
2019
Q4 | $878K | Buy |
28,062
+15,361
| +121% | +$481K | ﹤0.01% | 2378 |
|
2019
Q3 | $331K | Sell |
12,701
-418
| -3% | -$10.9K | ﹤0.01% | 2829 |
|
2019
Q2 | $300K | Sell |
13,119
-3,133
| -19% | -$71.6K | ﹤0.01% | 2985 |
|
2019
Q1 | $426K | Buy |
16,252
+5,913
| +57% | +$155K | ﹤0.01% | 2700 |
|
2018
Q4 | $210K | Buy |
+10,339
| New | +$210K | ﹤0.01% | 2699 |
|